Skip to main content

#161634

Rosetta E. coli for expression of GST and human CB1 receptor (AA 414 to 472) fusion protein

Cat. #161634

Rosetta E. coli for expression of GST and human CB1 receptor (AA 414 to 472) fusion protein

Cat. #: 161634

Availability: 3-4 weeks

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Gontzal García del Caño

Institute: University of the Basque Country

Primary Citation: Contact the inventor for further information.

Tool Details
Handling
Application Details
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Tool name: Rosetta E. coli for expression of GST and human CB1 receptor (AA 414 to 472) fusion protein
  • Research fields: Biochemistry;Cell biology;Molecular Biology;Neurobiology
  • Sequence: Saumell-Esnaola M et al. 2022. Microb Cell Fact. 21(1):192. PMID: 36109736.
  • Description: E. coli strain for the IPTG-inducible production of the polypeptide spanning amino acids 414 to 472 of the cytosolic tail of the human CB1 receptor (CB1414–472) fused to the C-terminus of the glutathione Stransferase (GST) tag.
  • Application: IPTG-inducible production of GST-CB1414–472 fusion protein.

Handling

  • Storage conditions: -80° C
  • Shipping conditions: Frozen in dry ice

Application Details

  • Application: IPTG-inducible production of GST-CB1414–472 fusion protein.

References

  • Saumell-Esnaola et al. 2022 Microb Cell Fact.21(1):192. PMID: 36109736
  • Gómez-Caballero et al. 2021. Mikrochim Acta. 188(11):368. PMID: 34618242.

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.